KLCM
IBB icon

KG&L Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

KG&L Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,751
Closed -$240K – 189
2024
Q1 		$240K Sell
1,751
-105
-6% -$14.3K 0.1% 160
2023
Q4 		$252K Sell
1,856
-254
-12% -$31K 0.11% 148
2023
Q3 		$258K Sell
2,110
-236
-10% -$30K 0.12% 131
2023
Q2 		$298K Sell
2,346
-245
-9% -$31.8K 0.14% 120
2023
Q1 		$335K Buy
2,591
+4
+0.2% +$524 0.18% 97
2022
Q4 		$340K Sell
2,587
-34
-1% -$4.39K 0.2% 94
2022
Q3 		$307K Sell
2,621
-182
-6% -$22.6K 0.17% 96
2022
Q2 		$330K Sell
2,803
-43
-2% -$5.1K 0.18% 93
2022
Q1 		$371K Buy
2,846
+506
+22% +$65.9K 0.15% 105
2021
Q4 		$357K Buy
+2,340
New +$362K 0.14% 110
2021
Q3 		– Sell
-3,781
Closed -$619K – 144
2021
Q2 		$619K Buy
+3,781
New +$582K 0.28% 82
2019
Q4 		– Sell
-2,218
Closed -$220K – 95
2019
Q3 		$220K Buy
+2,218
New +$232K 0.2% 89
2019
Q1 		– Sell
-4,949
Closed -$479K – 108
2018
Q4 		$479K Buy
+4,949
New +$525K 0.54% 54

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

KG&L Capital Management's IBB Position: Q2 2024 in Review

KG&L Capital Management sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 1,751 shares — an estimated $240K sold.

KG&L Capital Management first reported a position in IBB in Q4 2018 and held it in 13 quarters. The position peaked at $619K in Q2 2021. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

  • KG&L Capital Management reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
  • KG&L Capital Management sold 1,751 iShares Biotechnology ETF shares in Q2 2024, an estimated $240K.
  • KG&L Capital Management first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 13 quarters.
  • KG&L Capital Management's iShares Biotechnology ETF position peaked at $619K in Q2 2021.
  • 894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on KG&L Capital Management's 13F filing for Q2 2024, filed 23 Jul 2024.